Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, University Of Arkansas For Medical Science
2015
Residency, Sheth KM, Ahmedabad, India
2007
Doctor of Medicine, SMT NHL Municipal Medical College, Ahmedabad, India
2002
Fingerprint
Dive into the research topics where Zabeen Mahuwala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Facial Sympathetic Overactivity and Vascular Transduction Mechanistically Impact Menopause-Related Vasomotor Symptoms
Wilson, T. (PI), Mahuwala, Z. (CoI) & Metzler-Wilson, K. (CoI)
7/1/25 → 6/30/27
Project: Research project
-
-
IMVT-1401-3101: A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)
Mahuwala, Z. (PI)
10/12/22 → 8/16/26
Project: Research project
-
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial
for the Healey ALS Platform Trial Study Group, Aug 2025, In: Muscle and Nerve. 72, 2, p. 294-305 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study
Bril, V., Antozzi, C., Berkowicz, T., Drużdż, A., Gandhi Mehta, R. K., Mahuwala, Z. K., Zschüntzsch, J., Boehnlein, M., Kerbusch, V., Lavrov, A., Morris, M., Singh, P. & Leite, M. I., Oct 2025, In: Journal of Neurology. 272, 10, 686.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study
Habib, A. A., Sacconi, S., Antonini, G., Cortés-Vicente, E., Grosskreutz, J., Mahuwala, Z. K., Mantegazza, R., Pascuzzi, R. M., Utsugisawa, K., Vissing, J., Vu, T., Wiendl, H., Boehnlein, M., Greve, B., Woltering, F. & Bril, V., Jan 1 2024, In: Therapeutic Advances in Neurological Disorders. 17Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Nerve-Wracking Eye Puzzle: A Rare Case of Alpers-Huttenlocher Syndrome
Kini, A. T., Mahuwala, Z., Raslau, F. & Sudhakar, P., Mar 1 2023, In: Journal of Neuro-Ophthalmology. 43, 1, p. E6-E8Research output: Contribution to journal › Article › peer-review
-
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
MG0003 study team, May 2023, In: The Lancet Neurology. 22, 5, p. 383-394 12 p.Research output: Contribution to journal › Article › peer-review
193 Scopus citations